Figure 3From: Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma Quantitative differences of p16 protein expression. In liver tumors and non-neoplastic tissue samples the quantitative differences of p16 expression evaluated by immunohistochemical detection of p16 using an immunoreactivity score (IRS) are shown.Back to article page